Dexcom Inc (NASDAQ: DXCM) kicked off on Friday, down -2.19% from the previous trading day, before settling in for the closing price of $74.46. Over the past 52 weeks, DXCM has traded in a range of $62.34-$142.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 28.80% over the past five years. While this was happening, its average annual earnings per share was recorded 12.05%. With a float of $385.54 million, this company’s outstanding shares have now reached $390.60 million.
Let’s look at the performance matrix of the company that is accounted for 9600 employees. In terms of profitability, gross margin is 61.68%, operating margin of 15.88%, and the pretax margin is 18.81%.
Dexcom Inc (DXCM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Dexcom Inc is 1.29%, while institutional ownership is 93.16%. The most recent insider transaction that took place on Nov 20 ’24, was worth 318,275. In this transaction EVP, Chief HR Officer of this company sold 4,259 shares at a rate of $74.73, taking the stock ownership to the 71,192 shares. Before that another transaction happened on Nov 15 ’24, when Company’s EVP, Chief Financal Officer sold 3,500 for $75.51, making the entire transaction worth $264,285. This insider now owns 80,774 shares in total.
Dexcom Inc (DXCM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Take a look at Dexcom Inc’s (DXCM) current performance indicators. Last quarter, stock had a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.04. Likewise, its price to free cash flow for the trailing twelve months is 52.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.67, a number that is poised to hit 0.52 in the next quarter and is forecasted to reach 2.03 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Dexcom Inc (NASDAQ: DXCM) saw its 5-day average volume 3.62 million, a negative change from its year-to-date volume of 3.93 million. As of the previous 9 days, the stock’s Stochastic %D was 55.97%. Additionally, its Average True Range was 2.44.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 19.12%, which indicates a significant decrease from 49.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.01% in the past 14 days, which was lower than the 90.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.61, while its 200-day Moving Average is $101.42. Nevertheless, the first resistance level for the watch stands at $74.57 in the near term. At $76.32, the stock is likely to face the second major resistance level. The third major resistance level sits at $77.35. If the price goes on to break the first support level at $71.80, it is likely to go to the next support level at $70.77. Assuming the price breaks the second support level, the third support level stands at $69.02.
Dexcom Inc (NASDAQ: DXCM) Key Stats
The company with the Market Capitalisation of 27.82 billion has total of 390,595K Shares Outstanding. Its annual sales at the moment are 3,622 M in contrast with the sum of 541,500 K annual income. Company’s last quarter sales were recorded 994,200 K and last quarter income was 134,600 K.